USA - engelska - NLM (National Library of Medicine)

cameron pharmaceuticals - ferrous fumarate (unii: r5l488ry0q) (iron - unii:e1uol152h7) - ferrous fumarate 15 mg

USA - engelska - NLM (National Library of Medicine)

cameron pharmaceuticals, llc - hydrocortisone acetate (unii: 3x7931po74) (hydrocortisone - unii:wi4x0x7bpj) - hydrocortisone acetate suppositories are indicated for use in inflamed hemorrhoids, post-irradiation (factitial) proctitis, as an adjunct in the treatment of chronic ulcerative colitis, cryptitis, other inflammatory conditions of anorectum, and pruritus ani. hydrocortisone acetate suppositories are contraindicated in those patients having a history of hypersensitivity to hydrocortisone acetate or any of the components. drug abuse and dependence have not been reported in patients treated with hydrocortisone acetate suppositories.

USA - engelska - NLM (National Library of Medicine)

cameron pharmaceuticals, llc - selenium sulfide (unii: z69d9e381q) (selenium sulfide - unii:z69d9e381q) - selenium sulfide 2.3% shampoo is a liquid antiseborrheic, antifungal preparation useful for the treatment of seborrheic dermatitis of the scalp, dandruff and tinea versicolor. urea hydrates and is useful for conditions such as dry scalp. selenium sulfide 2.3% shampoo is contraindicated in persons with known or suspected hypersensitivity to any of the ingredients of the product.

USA - engelska - NLM (National Library of Medicine)

cameron pharmaceuticals - chlorzoxazone (unii: h0de420u8g) (chlorzoxazone - unii:h0de420u8g) - chlorzoxazone is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. the mode of action of this drug has not been clearly identified, but may be related to its sedative properties. chlorzoxazone does not directly relax tense skeletal muscles in man. chlorzoxazone is contraindicated in patients with known intolerance to the drug.

USA - engelska - NLM (National Library of Medicine)

cameron pharmaceuticals - chlorzoxazone (unii: h0de420u8g) (chlorzoxazone - unii:h0de420u8g) - chlorzoxazone is indicated as an adjunct to rest, physical therapy, and other measures for the relief of discomfort associated with acute, painful musculoskeletal conditions. the mode of action of this drug has not been clearly identified, but may be related to its sedative properties. chlorzoxazone does not directly relax tense skeletal muscles in man. chlorzoxazone is contraindicated in patients with known intolerance to the drug.

USA - engelska - NLM (National Library of Medicine)

cameron pharmaceuticals - phenobarbital sodium (unii: sw9m9bb5k3) (phenobarbital - unii:yqe403bp4d) - - sedative. sedation is obtainable within an hour, and in adequate dosage, the duration of action is more than six hours. included in the more common conditions in which the sedative action of this class of drugs is desired are anxiety-tension states, hyperthyroidism, essential hypertension, nausea and vomiting of functional origin, motion sickness, acute labyrinthitis, pylorospasm in infants, chorea and cardiac failure. phenobarbital is also a useful adjunct in treatment of hemorrhage from the respiratory or gastrointestinal tract. phenobarbital controls anxiety, decreases muscular activity and lessens nervous excitability in hyperthyroid patients. however, thyrotoxic individuals occasionally react poorly to barbiturates. - hypnotic, for the short-term treatment of insomnia, since it appears to lose its effectiveness for sleep induction and sleep maintenance after 2 weeks (see clinical pharmacology ). - preanesthetic. - long-term anticonvulsant, (phenobarbital, mephobarbital and metharbital) for the treatmen

USA - engelska - NLM (National Library of Medicine)

cameron pharmaceuticals - ribavirin (unii: 49717awg6k) (ribavirin - unii:49717awg6k) - ribavirin for inhalation solution, usp is indicated for the treatment of hospitalized infants and young children with severe lower respiratory tract infections due to rsv. treatment early in the course of severe lower respiratory tract infection may be necessary to achieve efficacy. only severe rsv lower respiratory tract infection should be treated with ribavirin for inhalation solution, usp. the vast majority of infants and children with rsv infection have disease that is mild, self-limited, and does not require hospitalization or antiviral treatment. many children with mild lower respiratory tract involvement will require shorter hospitalization than would be required for a full course of ribavirin for inhalation solution, usp aerosol (3 to 7 days) and should not be treated with the drug. thus the decision to treat with ribavirin for inhalation solution, usp should be based on the severity of the rsv infection. the presence of an underlying condition such as prematurity, immunosuppression or cardiopulmonar

USA - engelska - NLM (National Library of Medicine)

cameron pharmaceuticals - tetracaine hydrochloride (unii: 5nf5d4opci) (tetracaine - unii:0619f35cgv) - tetracaine hydrochloride is indicated for the production of spinal anesthesia for procedures requiring two to three hours. spinal anesthesia with tetracaine hydrochloride is contraindicated in patients with known hypersensitivity to tetracaine hydrochloride or to drugs of a similar chemical configuration (ester-type local anesthetics), or aminobenzoic acid or its derivatives; and in patients for whom spinal anesthesia as a technique is contraindicated. the decision as to whether or not spinal anesthesia should be used for an individual patient should be made by the physician after weighing the advantages with the risks and possible complications. contraindications to spinal anesthesia as a technique can be found in standard reference texts, and usually include generalized septicemia, infection at the site of injection, certain diseases of the cerebrospinal system, uncontrolled hypotension, etc.

USA - engelska - NLM (National Library of Medicine)

cameron pharmaceuticals, limited liability company - hydrocortisone acetate (unii: 3x7931po74) (hydrocortisone - unii:wi4x0x7bpj) - hydrocortisone acetate suppositories are indicated for use in inflamed hemorrhoids, post-irradiation (factitial) proctitis, as an adjunct in the treatment of chronic ulcerative colitis, cryptitis, other inflammatory conditions of anorectum, and pruritus ani. hydrocortisone acetate suppositories are contraindicated in those patients having a history of hypersensitivity to hydrocortisone acetate or any of the components. drug abuse and dependence have not been reported in patients treated with hydrocortisone acetate suppositories.

USA - engelska - NLM (National Library of Medicine)

cameron pharmaceuticals, limited liability company - hydrocortisone acetate (unii: 3x7931po74) (hydrocortisone - unii:wi4x0x7bpj) - hydrocortisone acetate suppositories are indicated for use in inflamed hemorrhoids, post-irradiation (factitial) proctitis, as an adjunct in the treatment of chronic ulcerative colitis, cryptitis, other inflammatory conditions of anorectum, and pruritus ani. hydrocortisone acetate suppositories are contraindicated in those patients having a history of hypersensitivity to hydrocortisone acetate or any of the components. drug abuse and dependence have not been reported in patients treated with hydrocortisone acetate suppositories.